Aspira Pathlab & Diagnostics Limited - Due diligence report

A 360° intelligence report on Aspira: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…

1973-07-03 Mumbai, Maharashtra Active Listed Active Compliant
Share
View plans
AP Aspira Pathlab & Diagnostics Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Aspira — 360° Intelligence Report

Generated from MCA filings & public records
94/100
Trust Score
Low Risk

Aspira is assessed as Low Risk with a Trust Score of 94/100. Aspira is an active public limited indian non-government company incorporated in 1973, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 02 Jul 2026 from the latest processed filings. Aspira Pathlab & Diagnostics Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
94/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 3 satisfied (6.22 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited3 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MANAS RAJENDRA MENGAR 01234567 Director 01/04/2018 6 yrs Approved
PANKAJ JASHWANT SHAH 01234567 Director 01/04/2018 6 yrs Approved
NIKUNJ VELJI MANGE 01234567 Director 01/04/2018 6 yrs Approved
HASEEB AHMAD DRABU 01234567 Director 01/04/2018 6 yrs Approved
PANKAJ JASHWANT SHAH 01234567 Director 01/04/2018 6 yrs Approved
BALKRISHNA SUBHASH TALAWADEKAR 01234567 Director 01/04/2018 6 yrs Approved
KRUPALI KIRTI KUMAR SHAH 01234567 Director 01/04/2018 6 yrs Approved
Kiran Raghavendra Awasthi 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 0 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Group entityRelationship% held
Yashraj Biotechnology Limited Associate Company 74.00%

Key managerial personnel: PANKAJ JASHWANT SHAH (CEO) · PANKAJ JASHWANT SHAH (Managing Director) · BALKRISHNA SUBHASH TALAWADEKAR (CFO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 52+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence92/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment94/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view93/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
12 Nov 2025
Director appointed
Kiran Raghavendra Awasthi (Additional Director)
26 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
25 Sep 2023
Director ceased
MANAS RAJENDRA MENGAR
09 Sep 2023
Director appointed
KRUPALI KIRTI KUMAR SHAH (Company Secretary)
12 Aug 2023
Director appointed
MANAS RAJENDRA MENGAR (Director)
11 Nov 2022
Director ceased
ARVIND KARSANDAS BHANUSHALI
07 Oct 2021
Charge satisfied
Hdfc Bank Limited
18 Jun 2021
Charge satisfied
Hdfc Bank Limited
05 Jun 2021
Director ceased
ABHAY SADASHIV CHOWDHARY
Director ceased
YASH ARVIND BHANUSHALI
02 Jun 2021
Charge satisfied
Hdfc Bank Limited
13 Feb 2021
Director appointed
BALKRISHNA SUBHASH TALAWADEKAR (CFO)
07 Jan 2021
Securities allotted
1000000 Equity Shares - 30.00 raised
29 Sep 2020
Director ceased
NIKUNJ VELJI MANGE
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Looks Health Services L93030MH2011PLC222636 Mumbai, Maharashtra, India
Medinovaindia L85110TG1993PLC015481 Hyderabad, Telangana, India
P H Diagnostic Centre Private Limited U85110PN1995PTC213675 Pune City, Maharashtra, India
Neuberg Diagnostics U85300TN2017PTC114099 Saidapet, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Aspira before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Aspira: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Aspira - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Aspira pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Aspira - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Aspira an active company?

Aspira has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Aspira financially healthy?

Aspira has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Aspira?

Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Aspira?

Promoters hold a minority stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Aspira have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Aspira up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Aspira?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.